Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Michigan for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Michigan only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Michigan (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Brandon Mancini (NPI 1366731838)

Field	Value
Entity Type	Individual
Organization	Brandon Mancini
Address	109 Michigan St Nw Ste 200
City	Grand Rapids
State	MI
ZIP	49503
Taxonomy	Radiation Oncology Physician
NPI Enumerated	April 5, 2011

Payer Source	Total Paid
Medicare	$4.6M
Medicaid	$0

Key Findings

This provider’s Medicare billing is highly concentrated in radioligand therapy: A9607 accounts for $4.5M of the $4.6M in total Medicare revenue and represents 97.8% of this provider's total Medicare revenue, with 23.2K claims and an average paid/claim of $193. The code’s profile and dollar volume indicate the practice is primarily delivering lutetium Lu 177 vipivotide tetraxetan therapeutic services rather than a broad mix of outpatient care.

The top three Medicare codes (A9607, 78832, 79101) together account for 99.6% of this provider's total Medicare revenue, signaling extreme revenue concentration in a small set of nuclear medicine and radiopharmaceutical procedures. That concentration implies the practice’s financial performance is highly dependent on continued utilization and reimbursement of these specific therapies.

Competitive standing for the leading therapeutic code is national-scale: A9607 ranks #3 of 44 providers nationally and is in the 95th percentile, described as notably above typical national volume for this code. The provider similarly ranks highly on companion nuclear medicine services—78832 is #5 of 145 (97th percentile, notably above typical national volume) and 79101 is #7 of 302 (98th percentile, notably above typical national volume)—together indicating this clinician is a major national participant in these specialized service lines.

Operational mix is procedure-forward with limited office evaluation-and-management volume: E/M codes such as 99205, 99214 and 99215 together contribute only small percentages of Medicare revenue (examples include 99205 at $9.2K and 99214 at $4.3K). This pattern suggests the provider’s role is centered on delivering high-volume therapeutic and imaging procedures rather than generating revenue from routine outpatient visits.

The provider reports no Medicaid billing on file, making their patient mix effectively single-payer from the claims present; total Medicare revenue is $4.6M while Total Medicaid revenue is none. For payers and network analysts, this means competitive and risk assessments should focus on Medicare reimbursement policies and contractor relationships for radiopharmaceuticals rather than state Medicaid program dynamics.

Several billed codes show unusual payment characteristics relative to peers: A9607’s high rank and the “notably above typical national volume” label indicate statistically exceptional utilization for a radiopharmaceutical, while 78832 and 79101 are also characterized as notably above typical national volume. These descriptors point to the provider being an outlier in delivering concentrated nuclear medicine and therapeutic radiopharmaceutical services at scale compared with national peers.

Tenure data show the NPI was enumerated on 2011-04-05 (~15 years ago), indicating a sustained presence in the market; the combination of long tenure and high volumes on a few specialty codes suggests an established, procedure-focused practice rather than recent episodic billing. This longevity should be considered when evaluating referral patterns and institutional relationships for specialized radioligand therapy in the region.

There are signs of billing items with negligible financial impact despite claim counts—J2405 shows 136 claims but $0 avg paid/claim and $0 revenue—highlighting areas where submitted services do not translate to Medicare payments. Analysts should treat such entries as administratively present but financially immaterial when modeling expected revenue streams or service-line profitability.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

8 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
A9607	Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie	23,210	$190	$4.5M
78832	The provider uses a nuclear imaging test called SPECT with concurrent CT imaging to localize a tumor, inflammatory process, or radioactive tracer distribution. Vascular flow and blood pool imaging…	110	$620	$69.6K
79101	In this procedure, the provider injects a radiopharmaceutical substance into the venous blood stream to treat the patient’s condition.	130	$110	$14.1K
99205	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider…	60	$150	$9.2K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	50	$80	$4.3K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	30	$120	$3.2K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	20	$110	$1.9K
J2405	Injection, ondansetron hydrochloride, per 1 mg	140	$0	$0

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 8 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Michigan Distribution

Brandon Mancini — 3 of 7 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Michigan

Full comparison — all codes billed, vs. state median

8 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
A9607	1	10	12,700	$190	$2.5M
78832	1	10	60	$570	$35.2K
99214	9,782	15,470	80	$80	$11.4K
99215	2,445	4,420	30	$110	$6K
99205	121	1,680	20	$150	$4.3K
99204	4,397	6,280	30	$110	$4.2K
79101	1	10	20	$90	$3.6K
J2405	19	30	270	$1	$40

Related Providers

Other providers that share a Tax Identification Number (TIN) with Brandon Mancini, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Mazen Mislmani	MI	Radiation Oncology Physician	$472.8K	$0
Jeremiah Johns	MI	Emergency Medicine Physician	$432.1K	$0
Simon Brown	MI	Radiation Oncology Physician	$425.8K	$0
Laura Ashack	MI	Radiation Oncology Physician	$386.6K	$0
Muhammad Hameed	MI	Medical Oncology Physician	$348.5K	$0
Garth Tormoen	NV	Radiation Oncology Physician	$321K	$0
Mohamad Fakhreddine	TX	Radiation Oncology Physician	$271.7K	$0
Anna Hoekstra	MI	Gynecologic Oncology Physician	$40.1K	$0
Gabriel Fine	CA	Nuclear Radiology Physician	$22.8K	$0
Michael Francisco	AZ	Physician Assistant	$19.3K	$0

Nearby Providers

Other providers in the same ZIP code as Brandon Mancini, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Spectrum Health Hospitals	MI	General Acute Care Hospital	$0	$243.2M
Kent County Cmh Authority	MI	Community/Behavioral Health Agency	$0	$97.6M
Saint Mary's Health Services	MI	General Acute Care Hospital	$0	$92M
Cancer & Hematology Centers Of Western Mi, P.C.	MI	Specialist	$0	$59.5M
Cherry Street Services, Inc.	MI	Federally Qualified Health Center (FQHC)	$0	$50.9M
Ecs Western Michigan PC	MI	Emergency Medicine Physician	$0	$50.6M
Neo Natal Associates Plc	MI	Neonatal-Perinatal Medicine Physician	$0	$27.7M
Spectrum Health Hospitals	MI	Hospitalist Physician	$0	$25.2M
Life Ems Inc	MI	Land Ambulance	$3.1M	$22M
Cherry Street Services, Inc.	MI	Federally Qualified Health Center (FQHC)	$0	$24.6M

Brandon Mancini — Billing Profile & Reimbursement Data

Sign up for Brandon Mancini — Billing Profile & Reimbursement Data policy alerts

Brandon Mancini — Billing Profile & Reimbursement Data

Sign up for Brandon Mancini — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References